Shares of toy maker Hasbro plummeted in premarket trading Monday after the company posted weaker-than-expected earnings following the liquidation of Toys R Us.
“As we discussed earlier in the year, our first quarter was expected to be difficult,” CEO Brian Goldner said in a statement Monday. “We are working to put the near-term disruption from Toys R Us behind us.”
Hasbro warned in February that residual effects from the bankruptcy of Toys R Us would weigh heavily on the brand for the first two quarters of 2018. Toys R Us said announced its liquidation last month.
Getty Images The board game Monopoly by toymaker Hasbro at a toy store in New York City.
Here’s what Hasbro reported compared with projections by a Thomson Reuters survey of analysts:
Top Gold Stocks To Invest In Right Now: CME Group Inc.(CME)
- [By Stephan Byrd]
Massachusetts Financial Services Co. MA cut its position in shares of CME Group (NASDAQ:CME) by 1.8% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund owned 445,259 shares of the financial services provider’s stock after selling 7,975 shares during the quarter. Massachusetts Financial Services Co. MA owned 0.13% of CME Group worth $72,016,000 as of its most recent filing with the SEC.
- [By Logan Wallace]
Get a free copy of the Zacks research report on CME Group (CME)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Logan Wallace]
Epoch Investment Partners Inc. grew its holdings in shares of CME Group Inc (NASDAQ:CME) by 51.9% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,545,562 shares of the financial services provider’s stock after purchasing an additional 528,198 shares during the period. Epoch Investment Partners Inc.’s holdings in CME Group were worth $249,980,000 at the end of the most recent quarter.
- [By ]
Sure, I will invest more in certain high-confidence picks than others, but without going overboard. This might limit the impact from a triple-digit winner in my High-Yield Investing portfolio, such as CME Group (Nasdaq: CME), where we are showing a 156% gain at last count, but it will also soften the blow from a laggard.
Top Gold Stocks To Invest In Right Now: NEW GOLD INC.(NGD)
- [By Paul Ausick]
New Gold Inc. (NYSEAMERICAN: NGD) dropped about 1.9% Tuesday to post a new 52-week low of $2.09. Shares closed at $2.13 on Monday and the stock’s 52-week high is $4.25. The junior gold miner had no specific news.
- [By Lisa Levin] Gainers
ARMO BioSciences, Inc. (NASDAQ: ARMO) shares rose 67.5 percent to $49.96 in pre-market trading after Eli Lilly and Company (NYSE: LLY) announced plans to acquire ARMO BioSciences for $50 per share.
Turtle Beach Corporation (NASDAQ: HEAR) rose 62.8 percent to $11.30 in pre-market trading after the company reported Q1 results and raised its FY18 outlook.
vTv Therapeutics Inc. (NASDAQ: VTVT) rose 23.4 percent to $2.11 in pre-market trading following announcement that the company will pre-specify new subgroup with the FDA and report Phase 3 Part B results in June.
Resonant Inc. (NASDAQ: RESN) rose 19.1 percent to $5.00 in pre-market trading after reporting Q1 results.
RXi Pharmaceuticals Corporation (NASDAQ: RXII) rose 17.7 percent to $2.39 in pre-market trading following Q1 results.
Clean Energy Fuels Corp. (NASDAQ: CLNE) rose 15.2 percent to $2.20 in pre-market trading after French company Total announced plans to acquire 25 percent stake in Clean Energy Fuels for $83.4 million.
Everspin Technologies, Inc. (NASDAQ: MRAM) rose 14.6 percent to $8.50 in pre-market trading after the company reported strong results for its first quarter.
Carvana Co. (NYSE: CVNA) shares rose 11 percent to $27.50 in pre-market trading after reporting upbeat Q1 sales.
Sunrun Inc. (NASDAQ: RUN) rose 8.9 percent to $10.70 in pre-market trading following upbeat quarterly earnings.
MediciNova, Inc. (NASDAQ: MNOV) rose 8.1 percent to $11.35 in pre-market trading after the company announced opening of Investigational New Drug Application for MN-166 (ibudilast) in glioblastoma.
New Gold Inc. (NYSE: NGD) shares rose 7.7 percent to $2.65 in pre-market trading after the company reported that its President and CEO Hannes Portmann left the company. The company named Raymond Threlkeld as successor.
Otter Tail Corporation (NASDAQ: OTTR) shares rose 7.4 percent to $46.60 in the pre-market trading session.
Himax Technologies, Inc. (NASDAQ: HIMX) shares rose
- [By Lisa Levin]
Check out these big penny stock gainers and losers
Teradyne, Inc. (NYSE: TER) fell 10.8 percent to $37.02 in pre-market trading after the company issued downbeat Q2 guidance.
Edwards Lifesciences Corporation (NYSE: EW) fell 9.2 percent to $122.29 in pre-market trading. Edwards Lifesciences reported better-than-expected results for its first quarter, but issued weak earnings guidance for the second quarter.
New Gold Inc. (NYSE: NGD) fell 8.8 percent to $2.30 in pre-market trading after rising 4.13 percent on Tuesday.
Gold Fields Limited (ADR) (NYSE: GFI) fell 8.6 percent to $3.61 in pre-market trading.
Natus Medical Incorporated (NASDAQ: BABY) fell 8.2 percent to $32.95 in pre-market trading after the company issued weak forecast for the second quarter.
Atossa Genetics Inc. (NASDAQ: ATOS) shares fell 7.9 percent to $3.50 in pre-market trading after climbing 27.09 percent on Tuesday.
Bright Scholar Education Holdings Limited (NYSE: BEDU) shares fell 6.7 percent to $13.58 in pre-market trading after reporting Q1 results.
Sangamo Therapeutics Inc (NASDAQ: SGMO) fell 5.9 percent to $16.75 in pre-market trading following announcement of a $200 million common stock offering.
Foresight Autonomous Holdings Ltd (NASDAQ: FRSX) shares fell 5.7 percent to $3.29 in pre-market trading after declining 3.32 percent on Tuesday.
Euronav NV (NYSE: EURN) fell 4.8 percent to $8.40 in pre-market trading.
Limelight Networks, Inc. (NASDAQ: LLNW) shares fell 4.3 percent to $4.69 in pre-market trading.
Gaming and Leisure Properties Inc (NASDAQ: GLPI) shares fell 4.1 percent to $32.92 in pre-market trading after the company issued downbeat quarterly results and reported the retirement of CFO William Clifford
Top Gold Stocks To Invest In Right Now: Orezone Gold Corp (ORE)
- [By Peter Graham]
Sandstorms due diligence is thorough, they dont just invest in any company. They like West Africa because they understand the area and the opportunities that exist there. Sandstorm is a royalty and streaming company, so they make these investments and receive cashflow deals that often kick in much later on. But they have already established a presence in Burkina and have deals in place with larger companies like Orezone Gold (TSXV: ORE) and Endeavour Mining (TSX: EDV). Sandstorms investment also potentially gives us access to their marketing department through something they call Launch Lab, and it looks like it will really benefit our own marketing efforts and will expose us to more opportunities over the coming year.
- [By Stephan Byrd]
Galactrum (ORE) is a PoW/PoS coin that uses the
Lyra2RE hashing algorithm. It launched on November 11th, 2017. Galactrum’s total supply is 2,092,679 coins and its circulating supply is 1,372,679 coins. Galactrum’s official Twitter account is @galactrum. Galactrum’s official website is galactrum.org.
- [By Jim Robertson]
Finally, Richard Seville, the CEO of Brisbane-based Orocobre Ltd (ASX: ORE) which began lithium sales in 2015 from northern Argentina and also experienced difficulty boosting output, commented that an inability to access traditional funds has delayed the development of the sector and that these projects arent easy — so the banks just dont want to go there.
Top Gold Stocks To Invest In Right Now: Northgate Minerals Corporation(NXG)
- [By Shane Hupp]
Shares of NEX Group PLC (LON:NXG) have been given an average rating of “Hold” by the nine ratings firms that are presently covering the company, Marketbeat.com reports. One research analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation and four have assigned a buy recommendation to the company. The average 1 year price objective among analysts that have issued ratings on the stock in the last year is GBX 696 ($9.21).